Post-traumatic osteoarthritis development is not modified by postnatal chondrocyte deletion of CCN2

CCN2 is a matricellular protein involved in several critical biological processes. In particular, CCN2 is involved in cartilage development and in osteoarthritis. CCN2 null mice exhibit a range of skeletal dysmorphisms, highlighting its importance in regulating matrix formation during development, however its role in adult cartilage remains unclear. The aim of this study was to determine the role of CCN2 in postnatal chondrocytes in models of post-traumatic osteoarthritis (PTOA). CCN2 deletion was induced in articular chondrocytes of male transgenic mice at 8 weeks of age. PTOA was induced in knees either surgically or non-invasively by repetitive mechanical loading at 10 weeks of age. Knee joints were harvested, scanned with micro-CT, and processed for histology. Sections were stained with toluidine blue and scored using the OARSI grading system. In the non-invasive model cartilage lesions were present in the lateral femur but no significant differences were observed between wildtype (WT) and CCN2 knockout (KO) mice 6 weeks post-loading. In the surgical model, severe cartilage degeneration was observed in the medial compartments but no significant differences were observed between WT and CCN2 KO mice at 2, 4, and 8 weeks post-surgery. We conclude that CCN2 deletion in chondrocytes did not modify the development of PTOA in mice, suggesting that chondrocyte expression of CCN2 in adults is not a critical player in protecting cartilage from the degeneration associated with PTOA. Summary Statement Post-natal deletion of CCN2 in chondrocytes does not affect the development of post-traumatic osteoarthritis in mice.

[1]  A. Didangelos,et al.  Connective tissue growth factor contributes to joint homeostasis and osteoarthritis severity by controlling the matrix sequestration and activation of latent TGFβ , 2018, Annals of the rheumatic diseases.

[2]  B. Perbal The concept of the CCN protein family revisited: a centralized coordination network , 2018, Journal of Cell Communication and Signaling.

[3]  B. Perbal Once upon a time ...A special issue for the 10th anniversary of the Journal of Cell Communication and Signaling , 2018, Journal of Cell Communication and Signaling.

[4]  P. Clegg,et al.  Differential tissue specific, temporal and spatial expression patterns of the Aggrecan gene is modulated by independent enhancer elements , 2018, Scientific Reports.

[5]  M. Brown,et al.  Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis , 2017, Arthritis Research & Therapy.

[6]  M. Young,et al.  WISP1/CCN4 aggravates cartilage degeneration in experimental osteoarthritis. , 2017, Osteoarthritis and cartilage.

[7]  M. Takigawa,et al.  CCN4/WISP-1 positively regulates chondrogenesis by controlling TGF-β3 function. , 2016, Bone.

[8]  M. Takigawa,et al.  Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions. , 2015, Clinical science.

[9]  J. Saklatvala,et al.  Generation of a mouse line harboring a bi‐transgene expressing luciferase and tamoxifen‐activatable creERT2 recombinase in cartilage , 2014, Genesis.

[10]  F. Barry,et al.  Mesenchymal stem cells in joint disease and repair , 2013, Nature Reviews Rheumatology.

[11]  T. Yamashiro,et al.  CCN Family Member 2/Connective Tissue Growth Factor (CCN2/CTGF) Has Anti-Aging Effects That Protect Articular Cartilage from Age-Related Degenerative Changes , 2013, PloS one.

[12]  T. Yamashiro,et al.  Cartilage–Specific Over-Expression of CCN Family Member 2/Connective Tissue Growth Factor (CCN2/CTGF) Stimulates Insulin-Like Growth Factor Expression and Bone Growth , 2013, PloS one.

[13]  S. Honsawek,et al.  Plasma and synovial fluid connective tissue growth factor levels are correlated with disease severity in patients with knee osteoarthritis , 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[14]  C. Little,et al.  The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. , 2010, Osteoarthritis and cartilage.

[15]  M. Takigawa,et al.  CCN family 2/connective tissue growth factor (CCN2/CTGF) stimulates proliferation and differentiation of auricular chondrocytes. , 2008, Osteoarthritis and cartilage.

[16]  V. Lefebvre,et al.  L-Sox5 and Sox6 Drive Expression of the Aggrecan Gene in Cartilage by Securing Binding of Sox9 to a Far-Upstream Enhancer , 2008, Molecular and Cellular Biology.

[17]  M. Barbe,et al.  Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF‐β1 to induce mesenchymal cell condensation , 2007, Journal of cellular physiology.

[18]  S. Kondo,et al.  Roles of PKC, PI3K and JNK in multiple transduction of CCN2/CTGF signals in chondrocytes. , 2006, Bone.

[19]  F. Mooren,et al.  Connective tissue growth factor/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage. , 2006, Arthritis and rheumatism.

[20]  Kozo Nakamura,et al.  Osteoarthritis development in novel experimental mouse models induced by knee joint instability. , 2005, Osteoarthritis and cartilage.

[21]  Changshan Wu,et al.  Retinoid Signaling Regulates CTGF Expression in Hypertrophic Chondrocytes With Differential Involvement of MAP Kinases , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  H. Inoue,et al.  Expression and localization of connective tissue growth factor (CTGF/Hcs24/CCN2) in osteoarthritic cartilage. , 2004, Osteoarthritis and cartilage.

[23]  Y. Tabata,et al.  Regeneration of Defects in Articular Cartilage in Rat Knee Joints by CCN2 (Connective Tissue Growth Factor) , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  B. Perbal CCN proteins: multifunctional signalling regulators , 2004, The Lancet.

[25]  B. Yoon,et al.  Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development , 2003, Development.

[26]  小林 哲人 神経膠腫におけるconnective tissue growth factor(CTGF)の発現とその血管新生への関与 , 2003 .

[27]  M. Takigawa,et al.  Role of CTGF/HCS24/ecogenin in skeletal growth control , 2003, Journal of cellular physiology.

[28]  S. Kondo,et al.  CTGF/Hcs24, a hypertrophic chondrocyte‐specific gene product, stimulates proliferation and differentiation, but not hypertrophy of cultured articular chondrocytes , 2002, Journal of cellular physiology.

[29]  H. Yatani,et al.  Regulatory mechanism of human connective tissue growth factor (CTGF/Hcs24) gene expression in a human chondrocytic cell line, HCS-2/8. , 2001, Journal of biochemistry.

[30]  Gary R. Grotendorst,et al.  Connective Tissue Growth Factor , 1992, The Journal of dermatology.

[31]  S. Yoshida,et al.  Retinoic Receptor Signaling Regulates Hypertrophic Chondrocyte-specific Gene Expression , 2018, In Vivo.

[32]  A. Pitsillides,et al.  Characterizing a novel and adjustable noninvasive murine joint loading model. , 2011, Arthritis and rheumatism.

[33]  M. Takigawa,et al.  Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. , 2000, Endocrinology.